✦ LIBER ✦

Value of CA 15.3 in breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis

✍ Scribed by E. Vizcarra; A. Lluch; R. Cibrián; F. Jarque; V. Alberola; V. Belloch; J. García-Conde

Publisher: Springer US
Year: 1996
Tongue: English
Weight: 650 KB
Volume: 37
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806502

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating CA 15-3 levels in the postsu

Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases

✍ Ramón Colomer; Alvaro Ruibal; José Genollá; Diego Rubio; Jose M. Del Campo; Ramo 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 839 KB

Bone scanning: Its lack of value in the

Bone scanning: Its lack of value in the follow-up of patients with breast cancer

✍ H. M. Bishop; R. W. Blamey; A. H. Morris; D. H. Rose; B. Preston; Joyce Lane; P. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

Further evaluation of the prognostic val

Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up

✍ Anne M. Uyterlinde; Jan P. A. Baak; Nellie W. Schipper; Hans Peterse; Erna Matze 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 635 KB

The added prognostic value of cellular DNA content compared with single and combined morphometric factors and classical parameters such as tumor size, nodal status, histologic grade and estrogen receptor (ER) content was investigated in 225 consecutive breast-cancer patients with long follow-up. Of

Disease-free interval and estrogen recep

Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

✍ J. M. M. Raemaekers; L. V. A. M. Beex; A. J. M. Koenders; G. F. F. M. Pieters; A 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 535 KB

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 3 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Long-term follow-up of autologous stem c

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission : The prognostic value of β2-microglobulin and the tumor score

✍ Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

BACKGROUND. The current study was conducted to analyze the long-term results of autologous stem cell transplantation (ASCT) in patients with diffuse mantle cell lymphoma (MCL) in first disease remission. METHODS. Thirty-three patients were treated. Thirty-one patients had Ann Arbor Stage III or Stag